Logo image of PCLA

PICOCELA INC (PCLA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PCLA - US71989C1099 - ADR

0.222 USD
-0.01 (-3.48%)
Last: 1/16/2026, 8:00:00 PM
0.2308 USD
+0.01 (+3.96%)
After Hours: 1/16/2026, 8:00:00 PM
Fundamental Rating

1

PCLA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 48 industry peers in the Communications Equipment industry. PCLA has a bad profitability rating. Also its financial health evaluation is rather negative. PCLA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • PCLA had negative earnings in the past year.
  • In the past year PCLA has reported a negative cash flow from operations.
PCLA Yearly Net Income VS EBIT VS OCF VS FCFPCLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -200M -400M -600M

1.2 Ratios

  • With a Return On Assets value of -86.63%, PCLA is not doing good in the industry: 89.58% of the companies in the same industry are doing better.
  • PCLA has a Return On Equity of -176.89%. This is amonst the worse of the industry: PCLA underperforms 85.42% of its industry peers.
Industry RankSector Rank
ROA -86.63%
ROE -176.89%
ROIC N/A
ROA(3y)-31.59%
ROA(5y)N/A
ROE(3y)-75.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PCLA Yearly ROA, ROE, ROICPCLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • The Gross Margin of PCLA (54.75%) is better than 70.83% of its industry peers.
  • The Profit Margin and Operating Margin are not available for PCLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCLA Yearly Profit, Operating, Gross MarginsPCLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50 -100

3

2. Health

2.1 Basic Checks

  • PCLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PCLA has a worse debt/assets ratio than last year.
PCLA Yearly Total Debt VS Total AssetsPCLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • PCLA has an Altman-Z score of -3.22. This is a bad value and indicates that PCLA is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -3.22, PCLA is doing worse than 70.83% of the companies in the same industry.
  • A Debt/Equity ratio of 0.03 indicates that PCLA is not too dependend on debt financing.
  • PCLA's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. PCLA outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -3.22
ROIC/WACCN/A
WACC1.47%
PCLA Yearly LT Debt VS Equity VS FCFPCLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500M -500M

2.3 Liquidity

  • A Current Ratio of 2.19 indicates that PCLA has no problem at all paying its short term obligations.
  • PCLA has a Current ratio of 2.19. This is in the better half of the industry: PCLA outperforms 60.42% of its industry peers.
  • PCLA has a Quick Ratio of 1.74. This is a normal value and indicates that PCLA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.74, PCLA is in the better half of the industry, outperforming 60.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 1.74
PCLA Yearly Current Assets VS Current LiabilitesPCLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M 1B

1

3. Growth

3.1 Past

  • PCLA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.06%.
  • PCLA shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.74%.
EPS 1Y (TTM)-50.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.87%
Revenue 1Y (TTM)23.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.3%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PCLA Yearly Revenue VS EstimatesPCLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 200M 400M 600M

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PCLA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCLA Price Earnings VS Forward Price EarningsPCLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCLA Per share dataPCLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for PCLA!.
Industry RankSector Rank
Dividend Yield 0%

PICOCELA INC

NASDAQ:PCLA (1/16/2026, 8:00:00 PM)

After market: 0.2308 +0.01 (+3.96%)

0.222

-0.01 (-3.48%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.85%
Inst Owner Change0%
Ins Owners8.07%
Ins Owner ChangeN/A
Market Cap7.68M
Revenue(TTM)1.04B
Net Income(TTM)-796.15M
AnalystsN/A
Price TargetN/A
Short Float %0.05%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.17
P/FCF N/A
P/OCF N/A
P/B 2.71
P/tB 2.98
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.19
BVpS0.08
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -86.63%
ROE -176.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.75%
FCFM N/A
ROA(3y)-31.59%
ROA(5y)N/A
ROE(3y)-75.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 194.6%
Cap/Sales 4.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 1.74
Altman-Z -3.22
F-Score6
WACC1.47%
ROIC/WACCN/A
Cap/Depr(3y)189.6%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.85%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.3%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y67.18%
OCF growth 3YN/A
OCF growth 5YN/A

PICOCELA INC / PCLA FAQ

What is the fundamental rating for PCLA stock?

ChartMill assigns a fundamental rating of 1 / 10 to PCLA.


What is the valuation status for PCLA stock?

ChartMill assigns a valuation rating of 0 / 10 to PICOCELA INC (PCLA). This can be considered as Overvalued.


What is the profitability of PCLA stock?

PICOCELA INC (PCLA) has a profitability rating of 1 / 10.